TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery

• Published in: Journal of controlled release 2023-03, Vol.355, p.579-592
• Main Authors: Ilahibaks, Nazma F., Ardisasmita, Arif I., Xie, Songpu, Gunnarsson, Anders, Brealey, Joseph, Vader, Pieter, de Jong, Olivier G., de Jager, Saskia, Dekker, Niek, Peacock, Ben, Schiffelers, Raymond M., Sluijter, Joost P.G., Lei, Zhiyong
• Format: Article
• Language: English
• Subjects: Active protein loading; Cell Communication; Drug Delivery Systems - methods; Endosomes; Extracellular vesicles; Extracellular Vesicles - metabolism; Functional intracellular protein delivery; Genome editing; Technology; TOP-EV
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2023.02.003

Extracellular vesicles (EVs) have emerged as biocompatible drug delivery vehicles due to their native ability to deliver bioactive cargo to recipient cells. However, the application of EVs as a therapeutic delivery vehicle is hampered by effective methods for endogenously loading target proteins inside EVs and unloading proteins after delivery to recipient cells. Most EV-based engineered loading methods have a limited delivery efficiency owing to their inefficient endosomal escape or cargo release from the intraluminal attachment from the EV membrane. Here, we describe the 'Technology Of Protein delivery through Extracellular Vesicles’ (TOP-EVs) as a tool for efficient intracellular delivery of target proteins mediated via EVs. The vesicular stomatitis virus glycoprotein and the rapamycin-heterodimerization of the FKBP12/T82L mutant FRB proteins were both important for the effective protein delivery through TOP-EVs. We showed that TOP-EVs could efficiently deliver Cre recombinase and CRISPR/Cas9 ribonucleoprotein complex in vitro. Moreover, our results demonstrated that the capacity of TOP-EVs to deliver intracellular proteins in recipient cells was not an artifact of plasmid contamination or direct plasmid loading into EVs. Finally, we showed that TOP-EVs could successfully mediate intracellular protein delivery in the liver in vivo. Taken together, TOP-EVs are a versatile platform for efficient intracellular protein delivery in vitro and in vivo, which can be applied to advance the development of protein-based therapeutics. [Display omitted] •TOP-EVs enable efficient proactive loading of diverse target proteins inside EVs.•TOP-EVs mediate efficient functional intracellular protein delivery.•TOP-EVs can be applied to mediate intracellular functional protein delivery for various applications in vitro and in vivo.